Stillidsvej 2 ApS: Financial statements 2023
CVR: 39012448
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Stillidsvej 2 ApS (CVR 39012448) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -6,250 and a net result of DKK -6,582 compared with DKK -4,893 the year before. Equity in the 2023 report amounted to DKK 15,134. The solvency ratio was 30.3%.
- Gross Profit
- DKK -6,250
- Profit/Loss
- DKK -6,582
- Equity
- DKK 15,134
- Total Assets
- DKK 50,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -6 t. | -7 t. | 15 t. | - |
| 2022 | - | -6 t. | -5 t. | 22 t. | - |
| 2021 | - | -6 t. | -4 t. | 27 t. | - |
| 2020 | - | -4 t. | -7 t. | 31 t. | - |
| 2019 | - | 0 | 4 t. | 37 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Stillidsvej 2 ApS has published its annual report for 2022. Gross profit came to DKK -6,250, and the net result was DKK -4,893.
About Stillidsvej 2 ApS
Stillidsvej 2 ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2017. The company is registered under the industry Detailhandel med andre fødevarer. The company was previously named CBD Pharma ApS. The management consists of Dan Ringsted Jacobsen and Lars Folkmann. The board consists of Dan Ringsted Jacobsen and Lars Folkmann. The company is owned by HPD Group ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,250 and a net result of DKK -6,350 compared with DKK -3,647 the year before. Equity in the 2025 report amounted to DKK 105,137.